相关实验视频

Updated: Sep 14, 2025

A Model of Chronic Nutrient Infusion in the Rat

A Model of Chronic Nutrient Infusion in the Rat

Published on: August 14, 2013

优化低血糖大鼠模型的优化策略

Lee Yeong Zher¹, Eason Kong Qi Zheng¹, Rayneshia Elaura Raymond²

¹Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Subang Jaya, Malaysia.

Animal models and experimental medicine

|July 22, 2025

概括

本综述探讨了研究低血糖影响和治疗植物治疗剂的老鼠模型. 优化这些模型是理解低血糖影响和改善患者生活质量的关键.

科学领域:

内分泌学和新陈代谢学
药理学药理学是指药理学的学科.
研究中的动物模型.

背景情况:

低血糖症,或低血糖,造成严重的健康风险.
了解其短期和长期影响对于患者护理至关重要.
现有研究强调了对优化实验模型的需求.

研究的目的:

审查和分析大鼠模型在研究低血糖的实用性.
探索在老鼠中低血糖后果背后的生理机制.
调查植物治疗剂在减轻低血糖的不良影响方面的疗效.

主要方法:

对利用老鼠模型进行低血糖研究的研究的文献综述.
在实验环境中对轻度和重度低血糖的生理反应的分析.
在临床前模型中对植物治疗干预措施的评估.

主要成果:

鼠标模型为急性和慢性低血糖提供了有价值的见解.
低血糖症的生理机制复杂且依赖于模型.
植物治疗剂显示出改善低血糖引起的损害的潜力.

结论:

优化的老鼠模型对于可靠的低血糖研究至关重要.
对植物治疗药物的进一步研究可能会导致新的治疗方法.
更好的理解将提高风险人群的生活质量.

关键词:

低血糖症是一种低血糖症.在体内研究研究体内研究.植物治疗剂植物治疗剂模拟老鼠模型的老鼠模型治疗发展的治疗方法.翻译研究是翻译研究.

更多相关视频

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

相关概念视频

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...